Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Multiple Myeloma 55Recurrence 14Neoplasms, Plasma Cell 9Primary Myelofibrosis 3Polycythemia Vera 3Neoplasms 3Waldenstrom Macroglobulinemia 2Plasmacytoma 2Myeloproliferative Disorders 2Hematologic Diseases 2Thrombocytosis 1Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Sarcoma, Kaposi 1Sarcoma 1Pancreatic Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Leukemia, Plasma Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Megakaryoblastic, Acute 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Glioma 1Ependymoma 1Central Nervous System Neoplasms 1

Interventions

ruxolitinib 2sonidegib 1pomalidomide 1luspatercept 1itacitinib 1Specimen Handling 1Prednisone 1INCB039110 1Hydroxyurea 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thrombocytosis × pomalidomide × Clear all
NCT00946270 2019-06-10

Pomalidomide for Myelofibrosis Patients

M.D. Anderson Cancer Center

Phase 2 Completed
70 enrolled 10 charts
Myeloid

Polycythemia Vera, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡